Charlotte Garcia

Charlotte Garcia

Auto-generated profile, based on publicly available information

Charlotte Garcia

Cambridge Hearing Group, Cambridge Mind and Brain Institute, University of Cambridge, 15 Chaucer Road, Cambridge, CB2 7EF, United Kingdom

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2021 in Journal of the Association for Research in Otolaryngology
Verified
Journal Article
Open access
PDF file
CGCharlotte Garcia
Charlotte Garcia
TGTobias Goehring
Tobias Goehring
SCStefano Cosentino
Stefano Cosentino
RTRichard E. Turner
Richard E. Turner
JDJohn M. Deeks
John M. Deeks
RCRobert P. Carlyon
Robert P. Carlyon
The knowledge of patient-specific neural excitation patterns from cochlear implants (CIs) can provide important information for optimizing efficacy and improving speech perception outcomes. The Panoramic ECAP (‘PECAP’) method (Cosentino et al. 2015) uses forward-masked electrically evoked compound action-potentials (ECAPs) to estimate neural activation patterns of CI stimulation. The algorithm requires ECAPs be measured for all combinations of probe and masker electrodes, exploiting the fact that ECAP amplitudes reflect the overlapping excitatory areas of both probes and maskers. Here we present an improved version of the PECAP algorithm that imposes biologically realistic constraints on the solution, that, unlike the previous version, produces detailed estimates of neural activation patterns by modelling current spread and neural health along the intracochlear electrode array and is capable of identifying multiple regions of poor neural health. The algorithm was evaluated for reliability and accuracy in three ways: (1) computer-simulated current-spread and neural-health scenarios, (2) comparisons to psychophysical correlates of neural health and electrode-modiolus distances in human CI users, and (3) detection of simulated neural ‘dead’ regions (using forward masking) in human CI users. The PECAP algorithm reliably estimated the computer-simulated scenarios. A moderate but significant negative correlation between focused thresholds and the algorithm’s neural-health estimates was found, consistent with previous literature. It also correctly identified simulated ‘dead’ regions in all seven CI users evaluated. The revised PECAP algorithm provides an estimate of neural excitation patterns in CIs that could be used to inform and optimize CI stimulation strategies for individual patients in clinical settings.

4 November 2020 in Journal of the Association for Research in Otolaryngology
Verified
Journal Article
Open access
PDF file
TBTim Brochier
Tim Brochier
FGFrançois Guérit
François Guérit
JDJohn M. Deeks
John M. Deeks
CGCharlotte Garcia
Charlotte Garcia
MBManohar Bance
Manohar Bance
RCRobert P. Carlyon
Robert P. Carlyon
Variations in neural health along the cochlea can degrade the spectral and temporal representation of sounds conveyed by cochlear implants (CIs). We evaluated and compared one electrophysiological measure and two behavioural measures that have been proposed as estimates of neural health patterns, in order to explore the extent to which the different measures provide converging and consistent neural health estimates. All measures were obtained from the same 11 users of the Cochlear Corporation CI. The two behavioural measures were multipulse integration (MPI) and the polarity effect (PE), both measured on each of seven electrodes per subject. MPI was measured as the difference between thresholds at 80 pps and 1000 pps, and PE as the difference in thresholds between cathodic- and anodic-centred quadraphasic (QP) 80-pps pulse trains. It has been proposed that good neural health corresponds to a large MPI and to a large negative PE (lower thresholds for cathodic than anodic pulses). The electrophysiological measure was the effect of interphase gap (IPG) on the offset of the ECAP amplitude growth function (AGF), which has been correlated with spiral ganglion neuron density in guinea pigs. This ‘IPG offset’ was obtained on the same subset of electrodes used for the behavioural measures. Despite high test–retest reliability, there were no significant correlations between the neural health estimates for either within-subject comparisons across the electrode array, or between-subject comparisons of the means. A phenomenological model of a population of spiral ganglion neurons was then used to investigate physiological mechanisms that might underlie the different neural health estimates. The combined experimental and modelling results provide evidence that PE, MPI and IPG offset may reflect different characteristics of the electrode-neural interface.

22 June 2023 in Advanced Healthcare Materials
Verified
Journal Article
Open access
SRSimone R. de Rijk
Simone R. de Rijk
ABAlexander J. Boys
Alexander J. Boys
Iwan Vaughan RobertsIwan Vaughan Roberts
Iwan Vaughan Roberts
CJChen Jiang
Chen Jiang
CGCharlotte Garcia
Charlotte Garcia
MBManohar Bance
Manohar Bance
Cochlear implants are a life‐changing technology for those with severe sensorineural hearing loss, partially restoring hearing through direct electrical stimulation of the auditory nerve. However, they are known to elicit an immune response resulting in fibrotic tissue formation in the cochlea that is linked to residual hearing loss and suboptimal outcomes. Intracochlear fibrosis is difficult to track without postmortem histology, and no specific electrical marker for fibrosis exists. In this study, a tissue‐engineered model of cochlear fibrosis is developed following implant placement to examine the electrical characteristics associated with fibrotic tissue formation around electrodes. The model is characterized using electrochemical impedance spectroscopy and an increase in the resistance and a decrease in capacitance of the tissue using a representative circuit are found. This result informs a new marker of fibrosis progression over time that is extractable from voltage waveform responses, which can be directly measured in cochlear implant patients. This marker is tested in a small sample size of recently implanted cochlear implant patients, showing a significant increase over two postoperative timepoints. Using this system, complex impedance is demonstrated as a marker of fibrosis progression that is directly measurable from cochlear implants to enable real‐time tracking of fibrosis formation in patients, creating opportunities for earlier treatment intervention to improve cochlear implant efficacy.

8 December 2022 in Ear & Hearing
Verified
Journal Article
Open access
CGCharlotte Garcia
Charlotte Garcia
JDJohn M. Deeks
John M. Deeks
TGTobias Goehring
Tobias Goehring
DBDaniele Borsetto
Daniele Borsetto
MBManohar Bance
Manohar Bance
RCRobert P. Carlyon
Robert P. Carlyon
Objectives: Electrically evoked compound action-potentials (ECAPs) can be recorded using the electrodes in a cochlear implant (CI) and represent the synchronous responses of the electrically stimulated auditory nerve. ECAPs can be obtained using a forward-masking method that measures the neural response to a probe and masker electrode separately and in combination. The panoramic ECAP (PECAP) analyses measured ECAPs obtained using multiple combinations of masker and probe electrodes and uses a nonlinear optimization algorithm to estimate current spread from each electrode and neural health along the cochlea. However, the measurement of ECAPs from multiple combinations of electrodes is too time consuming for use in clinics. Here, we propose and evaluate SpeedCAP, a speedy method for obtaining the PECAP measurements that minimizes recording time by exploiting redundancies between multiple ECAP measures. Design: In the first study, 11 users of Cochlear Ltd. CIs took part. ECAPs were recorded using the forward-masking artifact-cancelation technique at the most comfortable loudness level (MCL) for every combination of masker and probe electrodes for all active electrodes in the users’ MAPs, as per the standard PECAP recording paradigm. The same current levels and recording parameters were then used to collect ECAPs in the same users with the SpeedCAP method. The ECAP amplitudes were then compared between the two conditions, as were the corresponding estimates of neural health and current spread calculated using the PECAP method previously described by Garcia et al. The second study measured SpeedCAP intraoperatively in 8 CI patients and with all maskers and probes presented at the same current level to assess feasibility. ECAPs for the subset of conditions where the masker and probe were presented on the same electrode were compared with those obtained using the slower approach leveraged by the standard clinical software. Results: Data collection time was reduced from ≈45 to ≈8 minutes. There were no significant differences between normalized root mean squared error (RMSE) repeatability metrics for post-operative PECAP and SpeedCAP data, nor for the RMSEs calculated between PECAP and SpeedCAP data. The comparison achieved 80% power to detect effect sizes down to 8.2% RMSE. When between-participant differences were removed, both the neural-health (r = 0.73) and current-spread (r = 0.65) estimates were significantly correlated (p < 0.0001, df = 218) between SpeedCAP and PECAP conditions across all electrodes, and showed RMSE errors of 12.7 ± 4.7% and 16.8 ± 8.8%, respectively (with the ± margins representing 95% confidence intervals). Valid ECAPs were obtained in all patients in the second study, demonstrating intraoperative feasibility of SpeedCAP. No significant differences in RMSEs were detectable between post- and intra-operative ECAP measurements, with the comparison achieving 80% power to detect effect sizes down to 13.3% RMSE. Conclusions: The improved efficiency of SpeedCAP provides time savings facilitating multi-electrode ECAP recordings in routine clinical practice. SpeedCAP data collection is sufficiently quick to record intraoperatively, and adds no more than 8.2% error to the ECAP amplitudes. Such measurements could thereafter be submitted to models such as PECAP to provide patient-specific patterns of neural activation to inform programming of clinical MAPs and identify causes of poor performance at the electrode-nerve interface of CI users. The speed and accuracy of these measurements also opens up a wide range of additional research questions to be addressed.

22 May 2025 in Ear & Hearing
Verified
Journal Article
Open access
CGCharlotte Garcia
Charlotte Garcia
RCRobert P. Carlyon
Robert P. Carlyon
Objectives: Cochlear implant companies manufacture devices with different electrode array types. Some arrays have a straight geometry designed for minimal neuronal trauma, while others are precurved and designed to position the electrodes closer to the cochlear neurons. Due to their differing geometries, it is possible that the arrays are not only positioned differently inside the cochlea but also produce different patterns of the spread of current and of neural excitation. The panoramic electrically evoked compound action potential method (PECAP) provides detailed estimates of peripheral neural responsiveness and current spread for individual patients along the length of the cochlea. These estimates were assessed as a function of electrode position and array type, providing a normative dataset useful for identifying unusual patterns in individual patients. Design: ECAPs were collected from cochlear implant users using the forward-masking artifact-reduction technique for every combination of masker and probe electrode at the most comfortable level. Data were available for 91 ears using Cochlear devices, and 53 ears using Advanced Bionics devices. The Cochlear users had straight arrays (Slim Straight, CI-22 series, n = 35), or 1 of 2 precurved arrays (Contour Advance, CI-12 series, n = 43, or Slim Modiolar, CI-32 series, n = 13). Computed tomography scans were also available for 41 of them, and electrode-modiolus distances were calculated. The Advanced Bionics users had 1 of 2 straight arrays (1J, n = 9 or SlimJ, n = 20), or precurved arrays (Helix, n = 4 or Mid-Scala, n = 20). The ECAPs were submitted to the PECAP algorithm to estimate current spread and neural responsiveness along the length of the electrode array for each user. A linear mixed-effects model was used to determine whether there were statistically significant differences between different array types and/or for different electrodes, both for the PECAP estimates of current spread and neural responsiveness, as well as for the available electrode-modiolus distances. Correlations were also conducted between PECAP’s estimate of current spread and the electrode-modiolus distances. Results: For Cochlear users, significant effects of array type ( p = 0.001) and of electrode ( p < 0.001) were found on the PECAP’s current-spread estimate, as well as a significant interaction ( p = 0.006). Slim Straight arrays had a wider overall current spread than both the precurved arrays (Contour Advance and Slim Modiolar). The interaction revealed the strongest effect at the apex. A significant correlation between PECAP’s current-spread estimate and the electrode-modiolus distances was also found across subjects ( r = 0.516, p < 0.001). No effect of array type was found on PECAP’s estimate of current spread for the Advanced Bionics users ( p = 0.979). Conclusions: These results suggest that for users of the Cochlear device, precurved electrode arrays show narrower current spread within the cochlea than those with lateral-wall electrode arrays, with the strongest effect present at the apex. No corresponding effects of array type were found in the Advanced Bionics device. This could have implications for device selection in clinical settings, although the authors underscore that this is a post-hoc analysis and does not demonstrate a causal link wherein device selection can be expected to give rise to specific neural excitation patterns.

1 August 2025 in JASA Express Letters
Verified
Journal Article
Open access
CGCharlotte Garcia
Charlotte Garcia
FSFergio Sismono
Fergio Sismono
TGTobias Goehring
Tobias Goehring
FGFrançois Guérit
François Guérit
DADorothée Arzounian
Dorothée Arzounian
RCRobert P. Carlyon
Robert P. Carlyon
The health of the auditory nerve is a key factor for hearing outcomes in cochlear-implant patients. Many electrophysiological markers of auditory-neural health have been proposed, with varying predictive power and independence from non-neural factors. The “Failure Index” (FI), the ratio between stimulation current level and response magnitude of the electrically-evoked compound action potential (eCAP) was compared to the Panoramic eCAP method. Both methods predicted localized areas of reduced neural responsiveness in a group of human cochlear-implant users, but the FI showed a greater dependence on a non-neural factor, namely, the distances between the cochlear-implant electrodes and the auditory nerves.